Finding the best weight loss supplements for women (or anyone, really) can be like finding a needle in a haystack — except ...

The General Directorate of Drugs, Food, and Health Products (Digemaps) issued a public warning about unapproved weight-loss ...

Mitolyn has not limited its focus to just weight loss only. Its users are experiencing a number of other health benefits that ...

Shares of Eli Lilly, the seller of Zepbound, were down 2.7% to $718.50 after the close on Friday. Novo Nordisk, the maker of Wegovy, saw its stock decline 1.4% to $61.67. Shares of Hims & Hers, a ...

Health and Human Services Secretary Robert F. Kennedy Jr. has been a vocal critic of drugs like Ozempic which he said cloud ...

Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.

The Centers for Medicare & Medicaid Services said on Friday it did not move forward with a proposal put forth by the Biden ...

The agency had previously drawn up plans to cut roughly 18% to 20% of the 100,000-person workforce by the middle of May.